 |
|
 |
|
|
Cyprazepam
|
|
| Systematic (IUPAC) name | |
| 10-chloro-N-(cyclopropylmethyl)-3-hydroxy-2-phenyl- 3,6-diazabicyclo[5.4.0]undeca-1,6,8,10-tetraen-5-imine |
|
| Identifiers | |
| CAS number | 15687-07-7 |
| ATC code | none |
| PubChem | 27452 |
| Chemical data | |
| Formula | C19H18ClN3O |
| Mol. mass | 339.819 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Cyprazepam is a drug which is a sedative-hypnotic benzodiazepine derivative.[1][2][3][4] It has anxiolytic properties,[5] and presumably also has hypnotic, skeletal muscle relaxant, anticonvulsant and amnestic properties.
See also
References
- ^ Herbert Oelschläger; Doris Martienssen, F. Belal (22 September 2006). "Ring Contraction of 1,4-Benzodiazepines to 3,4-Dihydroquinazolines During Macro Scale Reduction (Example 5: Cyprazepam)". Archiv der Pharmazie (Wiley Interscience) 325 (8): 503–507. doi:. ISSN 0365-6233. http://www3.interscience.wiley.com/journal/113348763/abstract.
- ^ Bradley Matthews; Shashoua Victor, Webb Nigel, Swindell Charles (13 October 2004). "DHA-pharmaceutical agent conjugates - European Patent Application EP1466628". Patents online. http://www.freepatentsonline.com/EP1466628.html. Retrieved 19 September 2009.
- ^ "Harmonized Tariff Schedule of the United States (2009) - Supplement 1 - PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE" (PDF). USA: United States International Trade Commission. 2009. http://www.usitc.gov/publications/docs/tata/hts/bychapter/0910PHARMAPPX.pdf. Retrieved 19 September 2009.
- ^ E. W. Schafer; Jr W. A. Bowles, Jr, J. Hurlbut (1983). "The Acute Oral Toxicity, Repellency, and Hazard Potential of 998 Chemicals to One or More Species of Wild and Domestic Birds" (PDF). Arch. Environm. Contam. Toxicol (USA) 12 (3): 355–382. doi:. PMID 6882015. http://www.springerlink.com/content/q3r47rn103727752/fulltext.pdf. Retrieved 19 September 2009.
- ^ World Health Organisation (2006). "[http://www.moh.gov.sy/Pages/DrugAndNutrition/documents/INN%20Stems/RevisedFinalStemBook2006.pdf The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances]" (PDF). USA: Minstry of health, Syria. http://www.moh.gov.sy/Pages/DrugAndNutrition/documents/INN%20Stems/RevisedFinalStemBook2006.pdf. Retrieved 19 September 2009.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
